We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed: MDUFA Agreement Could Be “Game Changer” for FDA, Industry
AdvaMed: MDUFA Agreement Could Be “Game Changer” for FDA, Industry
February 3, 2012
A compromise reached by the FDA and device industry on medical device user fee reauthorization should benefit both parties and speed patient access to innovative technologies, AdvaMed President Stephen Ubl said.